Skip to main content

Table 1 Clinical characteristics of study participants with type 2 diabetes (n = 24)

From: Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring

Age, years 56.2 ± 8.9
Gender, male/female 14/10
Body mass index, kg/m2 26.7 ± 4.2
Duration of diabetes, years 5.3 ± 6.8
Systolic blood pressure, mmHg 122.6 ± 12.0
Diastolic blood pressure, mmHg 76.3 ± 11.0
Diabetes-related complications
 Neuropathy, n (%) 9 (37.0)
 Retinopathy, n (%) 7 (29.0)
 Nephropathy, n (%) 6 (25.0)
Fasting glucose, mmol/L 177.0 ± 56.0
IRI, μU/mL 9.3 ± 6.4
HbA1c, % 10.1 ± 2.4
Urinary CPR, μg/day 109.9 ± 61.2
AST, U/L 26.0 ± 12.3
ALT, U/L 28.1 ± 14.1
eGFR, mL/min/1.73 m2 86.1 ± 18.5
Uric acid, mg/dL 5.3 ± 1.3
  1. Data are mean ± SD or n (%)
  2. IRI immunoreactive insulin, HbA1c glycated hemoglobin, CPR C peptide immunoreactivity, eGFR estimated glomerular filtration rate